Biotech Venture Funding Deals March 2026: Complete List — Rounds, Investors & Therapeutic Area

Track March 2026 biotech venture funding: private rounds, deal size, investors, therapeutic area, and quick company summaries.

Biotech M&A Q1 2026

Q1 wrap of biotech/biopharma company-level control transactions announced in 2026 — target, acquirer, deal value, structure, premium, and a one-line “why it matters.”

Biotech M&A Q1 2026 Report: 16 Deals, $44B in Value, and What It Signals

A Q1 2026 biotech M&A recap covering 16 control transactions, the biggest biopharma acquisitions, therapeutic-area trends, and what the deal tape says about where buyers are paying up.

Biotech BD&L Deal Tracker February 2026 (Complete List: Upfronts, Milestones + Royalties)

Track February 2026 biotech/biopharma licensing + partnering deals — upfronts, milestones, royalties, rights/territory, and a one-line “why it matters.”

Biotech BD&L Deal Tracker January 2026 (Complete List: Upfronts, Milestones + Royalties)

Track January 2026 biotech/biopharma licensing + partnering deals — upfronts, milestones, royalties, rights/territory, and a one-line “why it matters.”